TY  - GEN
AU  - Bernardino,Jose I
AU  - Mocroft,Amanda
AU  - Wallet,Cedrick
AU  - de Wit,Stéphane
AU  - Katlama,Christine
AU  - Reiss,Peter
AU  - Mallon,Patrick W
AU  - Richert,Laura
AU  - Molina,Jean-Michel
AU  - Knobel,Hernando
AU  - Morlat,Philippe
AU  - Babiker,Abdel
AU  - Pozniac,Anton
AU  - Raffi,Francois
AU  - Arribas,Jose R
TI  - Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial
SN  - 1932-6203
PY  - 2019///0923
KW  - Adipokines
KW  - blood
KW  - Adult
KW  - Body Composition
KW  - Body Mass Index
KW  - Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
KW  - administration & dosage
KW  - Female
KW  - Fibroblast Growth Factor-23
KW  - Humans
KW  - Male
KW  - Raltegravir Potassium
KW  - Time Factors
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1371/journal.pone.0209911
ER  -